Eli Lilly and Company

Science has been our calling from the beginning. Colonel Eli Lilly founded the company in 1876 and charged employees to “take what you find here and make it better and better.” More than 147 years later, we remain committed to his vision through every aspect of our business and the people we serve, starting with discovering the best treatments for those who take our medicines and extending to health care professionals, employees and the communities in which we live. Moreover, you can also count on the team at Lilly to be incredibly civic-minded, supporting our communities through philanthropy, volunteerism, and a creative and innovative can-do spirit.

Karina found her fit at Lilly through our summer internship program. She is now hoping to inspire more Latinx students to make changes in the STEM field just as her mentor did for her. Visit careers.lilly.com/LRL to find open roles in Lilly’s research labs. #WeAreLilly

893 S Delaware St
Indianapolis, IN 46285

Discovery is
in our DNA

Exceptional people with an
extraordinary purpose.
Our values and commitment
have guided our success
for over 140 years.

Explore Careers

We are Lilly

Why do our employees love coming to work each and every day? Here’s what they have to say.

“Opportunity for growth is actually the biggest reason that I ended up hiring into Lilly.”

Kavita - Associate Director, Packaging Operations
“Lilly worked bery hard to be able to allow me to settle into my role, but they also had a great deal of consideration for my life outside of work.”

Adrian - Associate Director, IDM
“What we do matters, it matters to the people that we interact with. It matters to people in our families and it matters to people around the world.”

Cecile - Sr Director, Design Hub Foundations

39,000 global employees coming together from diverse backgrounds to create medicines that make life better for people around the world. Get to know us through our Powered by Purpose series.

View Stories

NEWS

Lilly Institute for Genetic Medicine building in Boston, Ma, USA, on November 11, 2023. Eli Lilly and Company is an American pharmaceutical company.

Government

Lilly Wins Medicare Coverage for Zepbound in Sleep Apnea

According to BMO Capital Markets, Medicare coverage of Lilly’s Zepbound opens the door to using secondary indications to secure CMS coverage for obesity drugs.

January 9, 2025

2 min read

Tristan Manalac

Podcast

NextGen Class of 2025, M&A Uptick Predicted Heading Into JPM, FDA Decisions to Watch

BioSpace presents 25 noteworthy biopharma startups in ’25; analysts forecast stronger M&A as the J.P. Morgan Healthcare Conference kicks off next week; GLP-1s continue to expand their reach as Novo, Lilly fight against compounders; and a look ahead to five key FDA decisions in Q1.

January 8, 2025

1 min read

Heather McKenzie

Partnered

All About Speed: Lilly Drives Innovation With New Facility to Help Bring Medicines to Market

Eli Lilly and Company has invested more than $20 billion in its manufacturing capabilities since 2020 to help meet high demand for its medicines. Its recently announced Lilly Medicine Foundry—which will support research and development efforts—is just the latest example of the ability to research new ways of producing medicines, while also scaling up manufacturing of medicines for clinical trials.

January 6, 2025

5 min read

BioSpace Insights

Symbol of money dollar from colored pills and capsules on green background. Expensive medicine and medical insurance

Venture Capitalists

Novo-Backed Oral Medicine Biotech Adds Lilly to Investors in $93M Series A

Orbis emerged from stealth in February 2024 with $28.1 million in seed funding. The Danish biotech, which aims to flip biologics into oral medicines, has now raised another $93 million.

January 6, 2025

1 min read

Annalee Armstrong

Opinion

Why Is Novo Outperforming Lilly Despite Having Inferior GLP-1 Products?

Novo Nordisk’s GLP-1s outsell Eli Lilly’s thanks to its superior marketing. Here’s how.

January 3, 2025

6 min read

Gary Stibel

Eli Lilly's world headquarters in Indianapolis

GLP-1

Lilly Asks to Join GLP-1 Compounding Lawsuit

Eli Lilly’s request to intervene in a suit filed by compounding pharmacies against the FDA reflects a belief the outcome could affect its business and that the FDA does not adequately represent its interests.

January 3, 2025

2 min read

Nick Paul Taylor

Sunset illuminates the tall skyscrapers of San Diego, California

Job Trends

7 Companies Hiring in California

Job postings in California took a dip in December during the holiday period, but activity is expected to pick up in January.

January 2, 2025

1 min read

Chantal Dresner

Pictured: A scientist works behind an FDA sign/Tay

FDA Tracker

2024 Ends With Lilly’s Landmark GLP-1 Sleep Apnea Approval

Other notable greenlights this year include Bristol Myers Squibb’s Cobenfy, the first novel therapeutic for schizophrenia in 35 years, and Madrigal Pharmaceuticals’ Rezdiffra, the first-ever treatment for MASH.

December 24, 2024

223 min read

BioSpace Editorial Staff

Eli Lilly's biotechnology center in California

GLP-1

Lilly’s Zepbound Snags First Ever Sleep Apnea Drug Approval

The mega-blockbuster weight loss GLP-1 drug is now also approved to treat obstructive sleep apnea in adults with obesity, in combination with diet and exercise.

December 23, 2024

2 min read

Kate Goodwin

JOBS